Metraipolis › archive › dc_ad6979eff25d

Rational design of hammerhead ribozymes as CD93 silencing tools for vascular diseases — Europe PMC PMID:42293250

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42293250
DOI: 10.1016/j.omtn.2026.102968
License (as archived): solo-consultazione
Archived: 2026-11-01T08:30:16.482Z
SHA-256 of the archived text: 9e37c3664b2efa4297fdecfbe5d479d76f00db317882b211a842f91c55e3e3a5
Stable URL of this page: https://metraipolis.com/documento/dc_ad6979eff25d

How to cite

Rational design of hammerhead ribozymes as CD93 silencing tools for vascular diseases — Europe PMC PMID:42293250 — Europe PMC (en), https://europepmc.org/article/MED/42293250 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad6979eff25d (Metraipolis archive dc_ad6979eff25d, sha256 9e37c3664b2efa4297fdecfbe5d479d76f00db317882b211a842f91c55e3e3a5)

BibTeX

@misc{dcad6979eff25d,
  title = {Rational design of hammerhead ribozymes as CD93 silencing tools for vascular diseases — Europe PMC PMID:42293250},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42293250},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad6979eff25d; sha256 9e37c3664b2efa4297fdecfbe5d479d76f00db317882b211a842f91c55e3e3a5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42293250. Agents can read the archived copy with the MCP tool read_document.